Joep G. Scholl

's-hertogenbosch, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases.

Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases.

Journal: Drug safety

Published: September 04, 2025

Detecting drug-related problems following metabolic and bariatric surgery using pharmacovigilance databases.

Detecting drug-related problems following metabolic and bariatric surgery using pharmacovigilance databases.

Journal: International journal of obesity (2005)

Published: August 26, 2025

Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy.

Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy.

Journal: Pharmacoepidemiology and drug safety

Published: March 25, 2024

Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.

Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.

Journal: Drug safety

Published: September 11, 2023

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.

Journal: Vaccine

Published: February 02, 2023

First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept.

First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept.

Journal: Expert opinion on drug safety

Published: January 23, 2023

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience.

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience.

Journal: Drug safety

Published: October 18, 2022

Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study.

Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study.

Journal: Expert opinion on drug safety

Published: August 29, 2022

Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database.

Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database.

Journal: Drug safety

Published: March 13, 2022

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.

Journal: Clinical and translational science

Published: November 06, 2019

Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions.

Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions.

Journal: Pharmacoepidemiology and drug safety

Published: August 20, 2018

Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors.

Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors.

Journal: Drug safety

Published: February 28, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026